Mumbai has emerged as a significant hub for pharmaceutical creation, with several firms specializing in the synthesis of Active Pharmaceutical Ingredients (APIs). Notably, a number of key enterprises are focused on the supply of Finasteride API (CAS No: 98319-26-7), meeting the global demand for